Posted inStock
Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules
By Jonathan Stempel NEW YORK (Reuters) -A U.S. appeals court on Friday revived a whistleblower lawsuit accusing Swiss drugmaker Novartis (SIX:NOVN) of paying illegal kickbacks to doctors to induce them…